Clinical phase II trial of recombinant dna interferon (interferon alfa 2b) in patients with metastatic malignant melanoma

Dorval, Thierry; Palangié, Thao; Jouve, Michel; García-Giralt, E; Israël, Lucien; Falcoff, E; Schwab, Denis; Pouillart, P

doi:10.1002/1097-0142(19860715)58:2<215::aid-cncr2820580202>3.0.co;2-p

Public

Clinical phase II trial of recombinant dna interferon (interferon alfa 2b) in patients with metastatic malignant melanoma

Published in Cancer • Jul 15, 1986

Authors:

Thierry Dorval

Thao Palangié

Michel Jouve

Abstract

Twenty-four patients with histologically proven metastatic malignant melanoma were included in a Phase II trial of human DNA recombinant interferon (rDNA IFN alpha 2). They were given 10 X 10(6) IU of IFN alpha 2 subcutaneously three times a week until progression of disease or major intolerance dev...

Subject

Medicine

Melanoma

Recombinant DNA

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!